Anthony Schwarer

Professor

19952019
If you made any changes in Pure these will be visible here soon.

Research Output 1995 2019

2019

Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia (Blood Cancer Journal, (2018), 8, 8, (68), 10.1038/s41408-018-0103-6)

Marquis, M., Beaubois, C., Lavallée, V. P., Abrahamowicz, M., Danieli, C., Lemieux, S., Ahmad, I., Wei, A., Ting, S. B., Fleming, S., Schwarer, A., Grimwade, D., Grey, W., Hills, R. K., Vyas, P., Russell, N., Sauvageau, G. & Hébert, J., 1 Mar 2019, In : Blood Cancer Journal. 9, 3, 1 p., 28.

Research output: Contribution to journalComment / DebateOtherpeer-review

Open Access

The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia

Minson, A. G., Cummins, K., Fox, L., Costello, B., Yeung, D., Cleary, R., Forsyth, C., Tatarczuch, M., Burbury, K., Motorna, O., Shortt, J., Fleming, S., McQuillan, A., Schwarer, A., Harrup, R., Holmes, A., Ratnasingam, S., Chan, K-L., Hsu, W-H., Ashraf, A. & 2 others, Putt, F. & Grigg, A., 9 Apr 2019, In : Blood Advances. 3, 7, p. 1084-1091 8 p.

Research output: Contribution to journalArticleResearchpeer-review

2018
2 Citations (Scopus)

Adaptive reprogramming of NK cells in X-Linked lymphoproliferative syndrome

Opat, S., Hearps, A. C., Thia, K., Yuen, A., Rogers, B., Chachage, M., Moore, G., Shortt, J., Ryland, G., Blombery, P., Schwarer, A. P., Noori, T., Trapani, J. A., Jaworowski, A. & Voskoboinik, I., 8 Feb 2018, In : Blood. 131, 6, p. 699-702 4 p.

Research output: Contribution to journalLetterOtherpeer-review

Combination of Nilotinib and Pegylated Interferon Alfa-2b Results in High Molecular Response Rates in Chronic Phase CML: Interim Results of the ALLG CML 11 Pinnacle Study: Blood 2018 132:459

Yeung, D. T., Grigg, A. P., Shanmuganathan, N., Cunningham, I., Shortt, J., Rowlings, P., Reynolds, J., Cushion, R., Harrup, R., Ross, D. M., Kipp, D., Mills, A. K., Arthur, C., Schwarer, A. P., Jackson, K., Viiala, N., Weinkove, R., Yong, A., White, D. L., Branford, S. & 1 others, Hughes, T. P., Nov 2018, In : Blood. 132, Suppl 1, p. 459-459 1 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2017

Efficacy and toxicity of PACEBOM chemotherapy in relapsed/refractory aggressive lymphoma in the rituximab era

Tamjid, B., Mckendrick, J., Schwarer, A., Doig, R., James, P., Hosking, P. & Hawkes, E. A., 1 Jun 2017, In : Asia-Pacific Journal of Clinical Oncology. 13, 3, p. 226-233 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia

Bradstock, K. F., Link, E., Di Iulio, J., Szer, J., Marlton, P., Wei, A., Enno, A., Schwarer, A., Lewis, I. D., Rozario, J. D., Coyle, L., Cull, G., Campbell, P., Leahy, M. F., Hahn, U. H., Cannell, P., Tiley, C., Lowenthal, R. M., Moore, J. & Cartwright, K., 20 May 2017, In : Journal of Clinical Oncology. 35, 15, p. 1678 - 1685 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Nilotinib in Combination with Pegylated Interferon Alfa-2b for CP-CML Leads to High Molecular Response Rates: Interim Results of the Pinnacle Study: Blood 2017 130:2898

Yeung, D., Grigg, A., Shanmuganathan, N., Cunningham, I., Shortt, J., Rowling, P., Reynolds, J., Cushion, R., Harrap, R., Ross, D. M., Kipp, D., Mills, A. K., Arthur, C. K., Schwarer, A. P., Jackson, K., Viiala, N., Weinkove, R., Yong, A. S. M., White, D. L., Branford, S. & 1 others, Hughes, T. P., 7 Dec 2017, In : Blood. 130, Suppl 1, 2898.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia

Fox, L. C., Cummins, K. D., Costello, B., Yeung, D., Cleary, R., Forsyth, C., Tatarczuch, M., Burbury, K., Motorna, O., Shortt, J., Fleming, S., McQuillan, A., Schwarer, A., Harrup, R., Holmes, A., Ratnasingam, S., Chan, K-L., Hsu, W-H., Ashraf, A., Putt, F. & 1 others, Grigg, A. P., 23 May 2017, In : Blood Advances. 1, 13, p. 802-811 10 p.

Research output: Contribution to journalArticleResearchpeer-review

The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study

Tan, P., Tiong, I. S., Fleming, S., Pomilio, G., Cummings, N., Droogleever, M., McManus, J., Schwarer, A., Catalano, J., Patil, S., Avery, S., Spencer, A. & Wei, A., 2017, In : Oncotarget. 8, 32, p. 52269-52280 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
2016
361 Citations (Scopus)

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): And randomised, phase 3, open-label, multicentre study

Dimopoulos, M. A., Moreau, P., Palumbo, A., Joshua, D. E., Pour, L., Hájek, R., Facon, T., Ludwig, H., Oriol, A., Goldschmidt, H., Rosiñol, L., Straub, J., Suvorov, A., Araujo, C., Rimashevskaya, E., Pika, T., Gaidano, G., Weisel, K. C., Goranova-Marinova, V., Schwarer, A. & 11 others, Minuk, L., Masszi, T., Karamanesht, I., Offidani, M., Hungria, V., Spencer, A., Orlowski, R. Z., Gillenwater, H. H., Mohamed, N., Feng, S. & Chng, W. J., 1 Jan 2016, In : Lancet Oncology. 17, 1, p. 27-38 12 p.

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)

Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era

Jalali, A., Ha, F. J., Chong, G., Grigg, A., Mckendrick, J., Schwarer, A. P., Doig, R., Hamid, A. & Hawkes, E. A., 1 Apr 2016, In : Annals of Hematology. 95, 5, p. 809-816 8 p.

Research output: Contribution to journalArticleResearchpeer-review

2015
5 Citations (Scopus)

The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit

Harrison, S. J. A., Quach, H., Link, E. K., Feng, H., Dean, J., Copeman, M. B., van de Velde, H., Schwarer, A., Baker, B., Spencer, A., Catalano, J., Campbell, P., Augustson, B. M., Romeril, K. & Prince, H. M., 2015, In : American Journal of Hematology. 90, 5, p. 86 - 91 6 p.

Research output: Contribution to journalArticleOther

2014
6 Citations (Scopus)

Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma

Campbell, P., Walker, P. A., Avery, S., Curtis, D. J., Schwarer, A., Wei, A., Kalff, A., Muirhead, J. L. & Spencer, A., 2014, In : Blood Cancer Journal. 4, 5, p. e213 - e213 3 p.

Research output: Contribution to journalLetterOther

2013
8 Citations (Scopus)

Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse

Fong, C. Y., Grigoriadis, G., Hocking, J., Coutsouvelis, J., Muirhead, J. L., Campbell, P., Paul, E., Walker, P. A., Avery, S., Patil, S., Spencer, A., Schwarer, A. & Wei, A., 2013, In : Leukemia and Lymphoma. 54, 2, p. 336 - 341 6 p.

Research output: Contribution to journalArticleResearchpeer-review

143 Citations (Scopus)

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

Morrissey, O., Chen, S. C-A., Sorrell, T. C., Milliken, S., Bardy, P., Bradstock, K. F., Szer, J., Halliday, C. L., Gilroy, N., Moore, J., Schwarer, A., Guy, S., Bajel, A., Tramontana, A. R., Spelman, T. D. & Slavin, M. A., 2013, In : Lancet Infectious Diseases. 13, 6, p. 519 - 528 10 p.

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)

High-dose cytarabine (24g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia

Low, M., Lee, D., Coutsouvelis, J., Patil, S., Opat, S., Walker, P. A., Schwarer, A., Salem, H. H., Avery, S., Spencer, A. & Wei, A., 2013, In : Internal Medicine Journal. 43, 3, p. 294 - 297 4 p.

Research output: Contribution to journalArticleResearchpeer-review

50 Citations (Scopus)

Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells

Heatley, S. L., Pietra, G., Lin, J., Widjaja, J. ML., Harpur, C. M., Lester, S., Rossjohn, J., Szer, J., Schwarer, A., Bradstock, K. F., Bardy, P., Mingari, M. C., Moretta, L., Sullivan, L. C. & Brooks, A., 2013, In : Journal of Biological Chemistry. 288, 12, p. 8679 - 8690 12 p.

Research output: Contribution to journalArticleResearchpeer-review

19 Citations (Scopus)

The impact of HLA-E polymorphisms on relapse following allogeneic hematopoietic stem cell transplantation

Hosseini, E., Schwarer, A., Jalali, A. & Ghasemzadeh, M., 2013, In : Leukemia Research. 37, 5, p. 516 - 519 4 p.

Research output: Contribution to journalArticleResearchpeer-review

2012
23 Citations (Scopus)

The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation

Hosseini, E., Schwarer, A. & Ghasemzadeh, M., 2012, In : Iranian Journal of Allergy, Asthma and Immunology. 11, 1, p. 15 - 21 7 p.

Research output: Contribution to journalArticleResearchpeer-review

2011

Complete Molecular Response (CMR) Rate with Nilotinib in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) without CMR After ≥ 2 Years on Imatinib: Preliminary Results From the Randomized ENESTcmr Trial of Nilotinib 400 Mg Twice Daily (BID) Vs Imatinib

Hughes, T. P., Lipton, J. H., Leber, B., Spector, N., Cervantes, F., Pasquini, R., Clementino, N., Schwarer, A. P., Mahon, F-X., Rea, D., Yeung, D. T., Kamel-Reid, S., Bendit, I., Reynolds, J., Williams, L., Szczudlo, T. & Branford, S., 18 Nov 2011, In : Blood. 118, 21, 606.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

14 Citations (Scopus)

Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies

Morrissey, C. O., Chen, S. C. A., Sorrell, T. C., Bradstock, K. F., Szer, J., Halliday, C. L., Gilroy, N. M., Schwarer, A. P. & Slavin, M. A., Feb 2011, In : Leukemia and Lymphoma. 52, 2, p. 179-193 15 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

2010
7 Citations (Scopus)

Cross-presentation of HCMV chimeric protein enables generation and measurement of polyclonal T cells

Nguyen, T. H. O., Sullivan, L. C., Kotsimbos, T. C., Schwarer, A. P. & Mifsud, N. A., 2010, In : Immunology and Cell Biology. 88, 6, p. 676 - 684 9 p.

Research output: Contribution to journalArticleResearchpeer-review

198 Citations (Scopus)

Patients with chronic myeloid leukaemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukaemia by DNA PCR

Ross, D., Branford, S., Seymour, J. F., Schwarer, A., Arthur, C. K., Bartley, P. A., Slader, C. A., Field, C., Dang, P., Filshie, R. J. A., Mills, A., Grigg, A. P., Melo, J. V. & Hughes, T. P., 2010, In : Leukemia. 24, 10, p. 1719 - 1724 6 p.

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Phase II study of autologous stem cell transplant using busulfanmelphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma

Grigg, A., Stone, J., Milner, A., Schwarer, A., Wolf, M., Prince, M., Seymour, J., Gill, D., Ellis, D. & Bashford, J., 2010, In : Leukemia and Lymphoma. 51, 4, p. 641 - 649 9 p.

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: Eighty-month follow-up

Patil, S., Spencer, A., Schwarer, A., Lewis, I., Hertzberg, M. S., Avery, S., Wei, A., Noutsos, T., Paul, E., Taouk, Y. & Muirhead, J. L., 2010, In : Bone Marrow Transplantation. 45, p. 1154 - 1160 6 p.

Research output: Contribution to journalArticleResearchpeer-review

49 Citations (Scopus)

Telomerase in cancer immunotherapy

Liu, J-P., Chen, W., Schwarer, A. & Li, H., 2010, In : Biochimica et Biophysica Acta - Reviews on Cancer. 1805, 1, p. 35 - 42 8 p.

Research output: Contribution to journalArticleResearchpeer-review

2008
76 Citations (Scopus)

Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade

Sutherland, J. S., Spyroglou, L. G., Muirhead, J. L., Heng, T. S. P., Prieto-Hinojosa, A., Prince, H. M., Chidgey, A. P., Schwarer, A. P. & Boyd, R. L., 2008, In : Clinical Cancer Research. 14, 4, p. 1138 - 1149 12 p.

Research output: Contribution to journalArticleResearchpeer-review

133 Citations (Scopus)

Impact of early dose intensity on cytogenetic and molecular responses in chronicphase CMLpatients receiving 600 mg/day of imatinib as initial therapy

Hughes, T. P., Branford, S., White, D. L., Reynolds, J., Koelmeyer, R., Seymour, J. F., Taylor, K., Arthur, C., Schwarer, A., Morton, J., Cooney, J., Leahy, M. F., Rowlings, P., Catalano, J., Hertzberg, M., Filshie, R., Mills, A. K., Fay, K., Durrant, S., Januszewicz, H. & 5 others, Joske, D., Underhill, C., Dunkley, S., Lynch, K. & Grigg, A., 15 Nov 2008, In : Blood. 112, 10, p. 3965-3973 9 p.

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

Refinement in the production and purification of recombinant HCMV IE1-pp65 protein for the generation of epitope-specific T cell immunity

Nguyen, T. H. O., Mifsud, N. A., Stewart, L. A., Rose, M. J., Etto, T. L., Williamson, N. A., Purcell, A. W., Kotsimbos, T. C. & Schwarer, A., 2008, In : Protein Expression and Purification. 61, 1, p. 22 - 30 9 p.

Research output: Contribution to journalArticleResearchpeer-review

15 Citations (Scopus)

The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma

Hiwase, D. K., Hiwase, S., Bailey, M. J., Bollard, G. M. & Schwarer, A., 2008, In : Cytotherapy. 10, 5, p. 507 - 517 11 p.

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Urinary cytology in multiple myeloma

Patil, S., Schwarer, A. & McLean, C. A., 2008, In : Cytopathology. 19, 2, p. 130 - 131 2 p.

Research output: Contribution to journalLetterOther

89 Citations (Scopus)

Brief report: The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia

Catalano, A., Dawson, M. A., Somana, K., Opat, S., Schwarer, A., Campbell, L. J. & Iland, H., 1 Dec 2007, In : Blood. 110, 12, p. 4073-4076 4 p.

Research output: Contribution to journalArticleResearchpeer-review

24 Citations (Scopus)

Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin A

Morrissey, O., Slavin, M. A., O'Reilly, M. A., Daffy, J. R., Seymour, J. F., Schwarer, A. & Szer, J., 2007, In : Mycoses. 50, Supplement 1, p. 24 - 37 14 p.

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Efficacy and safety of imatinib in patients with chronic myeloid leukemia and complete or near-complete cytogenetic response to interferon-α

Branford, S., Hughes, T., Milner, A., Koelmeyer, R., Schwarer, A., Arthur, C., Filshie, R., Moreton, S., Lynch, K. & Taylor, K., 15 Aug 2007, In : Cancer. 110, 4, p. 801-808 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Expression and purification of the minor histocompatibility antigen, HA-1H generated in Escherichia coli

Etto, T., Stewart, L., Nguyen, T. H. O., Williamson, N., Purcell, A. & Schwarer, A., 2007, In : Protein Expression and Purification. 54, 1, p. 176 - 182 7 p.

Research output: Contribution to journalArticleResearchpeer-review

36 Citations (Scopus)

Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma

Hiwase, D., Bollard, G. M., Hiwase, S., Bailey, M. J., Muirhead, J. L. & Schwarer, A. P., 2007, In : Cytotherapy. 9, 6, p. 539 - 547 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Kappa immunoglobulin light chain polymorphisms and survival after allogeneic transplantation for B-cell malignancies: a potential graft-vs-leukaemia target

Etto, T. L., Stewart, L. A., Muirhead, J. L., Bailey, M. J. & Schwarer, A. P., 2007, In : Tissue Antigens. 69, 1, p. 56 - 61 6 p.

Research output: Contribution to journalArticleOther

2006
8 Citations (Scopus)

CD34+ -derived CD11c+++ BDCA-1++ CD123 ++ DC: Expansion of a phenotypically undescribed myeloid DC1 population for use in adoptive immunotherapy

Ward, K., Stewart, L. A. & Schwarer, A., 2006, In : Cytotherapy. 8, 2, p. 130 - 140 11 p.

Research output: Contribution to journalArticleResearchpeer-review

51 Citations (Scopus)

Pamidronate Reduces Bone Loss after Allogeneic Stem Cell Transplantation

Grigg, A. P., Shuttleworth, P., Reynolds, J., Schwarer, A. P., Szer, J., Bradstock, K., Hui, C., Herrmann, R. & Ebeling, P. R., 1 Oct 2006, In : Journal of Clinical Endocrinology and Metablism. 91, 10, p. 3835-3843 9 p.

Research output: Contribution to journalArticleResearchpeer-review

2005

Correlation between disparity for the kappa immunoglobulin light chain and survival outcomes after allogeneic transplantation for B cell malignancies

Etto, T. L., Stewart, L. A., Muirhead, J. L. & Schwarer, A., 2005, In : Tissue Antigens. 66, 5, p. 407 - 408 2 p.

Research output: Contribution to journalLetterOther

Peripheral blood stem cell (PBSC) mobilization in patients with multiple myeloma: Low dose versus intermediate dose cyclophosphamide

Schwarer, A., McKendrick, J. & Bollard, G. M., 2005, In : Blood. 106, 11, p. 822A - 823A 2 p.

Research output: Contribution to journalLetterOther

24 Citations (Scopus)
2004
2 Citations (Scopus)
2003
11 Citations (Scopus)

Cytomegalovirus viral load monitoring after allogeneic bone marrow transplantation in patients receiving antiviral prophylaxis

Howden, B. P., Michaelides, A., Spelman, D. W., Spencer, A., Schwarer, A. P., Wesselingh, S. L. & Kotsimbos, T. C., 2003, In : Bone Marrow Transplantation. 32, 8, p. 795 - 800 6 p.

Research output: Contribution to journalArticleResearchpeer-review

1997
3 Citations (Scopus)

Acute pancreatitis complicating a bone marrow harvest

Beamish, N., Schwarer, A. P., Watson, A-M., Roberts, S., O'Brien, P. E. & Morgan, B., 1997, In : Bone Marrow Transplantation. p. 525 - 526 2 p.

Research output: Contribution to journalArticleResearchpeer-review